InvestSMART

Cochlear Limited (ASX: COH) - Announcements

Current share price for COH : $131.130 2.41 (1.87%)+

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8,576 Appendix 3Z - Chris Roberts 1 Sep 2015 10:32AM $84.670 $131.130 risen by 54.87%
$8,576 Appendix 3B 1 Sep 2015 10:25AM $84.670 $131.130 risen by 54.87%
$8,576 Appendix 3B 31 Aug 2015 3:49PM $85.330 $131.130 risen by 53.67%
$8,576 CEO HANDOVER EFFECTIVE AND RELATED BOARD CHANGES 31 Aug 2015 12:56PM $85.040 $131.130 risen by 54.20%
$8,576 Appendix 3Y - Chris Roberts 27 Aug 2015 12:24PM $86.600 $131.130 risen by 51.42%
$8,576 Appendix 3B 25 Aug 2015 11:29AM $85.850 $131.130 risen by 52.74%
$8,576 Appendix 3Y - Glen Boreham 24 Aug 2015 10:07AM $84.040 $131.130 risen by 56.03%
$8,576 Appendix 3Y - Dr Chris Roberts 21 Aug 2015 9:58AM $84.710 $131.130 risen by 54.80%
$8,576 Appendix 3Y - Rick Holliday-Smith 17 Aug 2015 10:02AM $85.000 $131.130 risen by 54.27%
$8,576 Dividend/Distribution - COH 12 Aug 2015 9:45AM $83.560 $131.130 risen by 56.93%
$8,576 COH Full Year Results Analyst Presentation 11.08.2015 11 Aug 2015 1:54PM $81.920 $131.130 risen by 60.07%
$8,576 Full Year Statutory Accounts and Annual Report 11 Aug 2015 9:11AM $90.040 $131.130 risen by 45.64%
$8,576 Updated Trading Policy 30 Jun 2015 12:29PM $79.270 $131.130 risen by 65.42%
$8,576 COH Chris Smith Announced as Incoming CEO of Cochlear 26 May 2015 8:34AM $87.460 $131.130 risen by 49.93%
$8,576 Judgment in United States Patent Infringement Lawsuit 21 Apr 2015 9:56AM $87.600 $131.130 risen by 49.69%
$8,576 DECISION IN US PATENT INFRINGEMENT CASE 1 Apr 2015 12:13PM $91.320 $131.130 risen by 43.59%
$8,576 Half Year Report & Accounts 10 Feb 2015 9:22AM $87.800 $131.130 risen by 49.35%
$8,576 COH Full Year Results Media Release 05.08.14 5 Aug 2014 9:40AM $69.000 $131.130 risen by 90.04%
$8,576 Preliminary Final Report and Full Year Statutory Accounts 5 Aug 2014 9:38AM $69.000 $131.130 risen by 90.04%
$8,576 COCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROP 2 Jun 2014 8:28AM $61.500 $131.130 risen by 113.22%
$8,576 FDA approves Cochlear Nucleus Hybrid for sale in USA 21 Mar 2014 8:52AM $58.960 $131.130 risen by 122.41%
$8,576 Half Year Report & Accounts 11 Feb 2014 9:00AM $53.680 $131.130 risen by 144.28%
$8,576 COH Jury Trial Verdict on USA Patent Infringement Case 24 Jan 2014 1:10PM $57.850 $131.130 risen by 126.67%
$8,576 Hybrid Hearing Device Update 11 Nov 2013 9:14AM $57.140 $131.130 risen by 129.49%
$8,576 15/10/13 Chairmans AGM Address to Shareholders 15 Oct 2013 9:46AM $58.760 $131.130 risen by 123.16%

876 - 900 of 944 results

Page 36 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.